β-Blocker pharmacogenetics in heart failure

التفاصيل البيبلوغرافية
العنوان: β-Blocker pharmacogenetics in heart failure
المؤلفون: Julie A. Johnson, Steven G. Terra
المصدر: Heart Failure Reviews. 15:187-196
بيانات النشر: Springer Science and Business Media LLC, 2008.
سنة النشر: 2008
مصطلحات موضوعية: medicine.medical_specialty, Adrenergic beta-Antagonists, Adrenergic, Article, Adrenergic beta-2 Receptor Antagonists, Internal medicine, medicine, Humans, Metoprolol, Heart Failure, Polymorphism, Genetic, business.industry, medicine.disease, Adrenergic beta-1 Receptor Antagonists, Alpha-1A adrenergic receptor, Tolerability, Pharmacogenetics, Heart failure, Anesthesia, Cardiology, Receptors, Adrenergic, beta-2, Receptors, Adrenergic, beta-1, Cardiology and Cardiovascular Medicine, business, medicine.drug
الوصف: Beta-blockers (metoprolol, bisoprolol, and carvedilol) are a cornerstone of heart failure (HF) treatment. However, it is well recognized that responses to a beta-blocker are variable among patients with HF. Numerous studies now suggest that genetic polymorphisms may contribute to variability in responses to a beta-blocker, including left ventricular ejection fraction improvement, survival, and hospitalization due to HF exacerbation. This review summarizes the pharmacogenetic data for beta-blockers in patients with HF and discusses the potential implications of beta-blocker pharmacogenetics for HF patients.
تدمد: 1573-7322
1382-4147
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5319128e92096b95c0ad71e9e984f707Test
https://doi.org/10.1007/s10741-008-9094-xTest
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....5319128e92096b95c0ad71e9e984f707
قاعدة البيانات: OpenAIRE